Evidence map›Paper›PMID 37803327›Full record

ArticleBMC psychiatry2023

Evaluating the association of vitamin D3, parathyroid hormone, and C-reactive protein serum levels in patients with an acute psychotic episode: a cross-sectional study in tertiary centre in Iran.

Shahrzad Arya, Amirhossein Kamyab, Seyed Amir Sanatkar, Mohammad Pourmehdiardebili, Alireza Ebrahimi, Parnia Kamyab, Kaveh Alavi, Zhina Zarei, Hamid Reza Ahmadkhaniha

Open access · goldAbstract read
In one paragraph

Article in BMC psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Shahrzad AryaResearch Center for Addiction and Risky Behaviors, Iran University of Medical Sciences, Tehran, Iran.
Amirhossein KamyabFaculty of Medicine, Fasa University of Medical Sciences, Fasa, Iran.
Seyed Amir SanatkarArak University of Medical Sciences, Arak, Iran.
Mohammad PourmehdiardebiliGolestan University of Medical Sciences, Gorgan, Iran.
Alireza EbrahimiStudent Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
Parnia KamyabFaculty of Medicine, Fasa University of Medical Sciences, Fasa, Iran.
Kaveh AlaviDepartment of Psychiatry, Mental Health Research Center, School of Behavioral Sciences & Mental Health (Tehran Institute of Psychiatry), Iran University of Medical Sciences, Tehran, Iran.
Zhina ZareiResearch Center for Addiction and Risky Behaviors, Iran University of Medical Sciences, Tehran, Iran.
Hamid Reza AhmadkhanihaResearch Center for Addiction and Risky Behaviors, Iran University of Medical Sciences, Tehran, Iran. Dr_ahmadkhaniha@yahoo.com.
Iran University of Medical Sciences · IRFasa University of Medical Sciences · IRArak University of Medical Sciences · IRGolestan University of Medical Sciences · IRShiraz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe high impact of vitamin D on brain development and its relationship with inflammatory markers in the clinical course of psychiatric disorders have compelled researchers to investigate the potential association between vitamin D levels, C-reactive protein (CRP) levels, and the incidence of mental disorders. In the present study, we aimed to compare the serum levels of vitamin D and its related markers, including calcium, phosphorus, and parathyroid hormone (PTH), along with CRP, in 3 groups of patients with acute psychotic episodes, including schizophrenia, bipolar disorder, and methamphetamine-induced psychosis, with a standard control group of the Iranian population.

methodsThis descriptive cross-sectional study was conducted at a psychiatric hospital in Tehran, Iran, and involved a total of 185 subjects. The subjects included four groups: acute phase of schizophrenia (n = 49), acute manic episodes of bipolar disorder (n = 43), methamphetamine-induced psychotic disorder (n = 46), and control group (n = 47). Among 138 patients in acute psychotic episodes, 33 patients were in their first episode of psychosis, while 105 patients were in acute exacerbation of their chronic psychotic disorders. The Brief Psychiatric Rating Scale (BPRS) was measured by an expert attending psychiatrist for all patients. Then, serum levels of calcium, phosphorus, parathormone, vitamin D, and CRP were assessed in all study groups.

resultsAmong our 185 study subjects, it was observed that individuals with higher education levels and those who were married had a lower prevalence of mental disorders. In all patient groups, the serum levels of CRP were significantly higher, and PTH levels were significantly lower than in the control group (p < 0.001). The serum levels of calcium, phosphorus, and vitamin D were not statistically significantly different between the patient and control groups of the study. In chronic psychotic patients, CRP levels were significantly higher (p < 0.031), and vitamin D levels were significantly lower (p < 0.044) compared to first-episode psychotic patients.

conclusionThis study suggests that CRP levels are significantly higher and PHT level is significantly lower in acute psychotic patients. Moreover, vitamin D levels were significantly lower in chronic psychotic patients compared to first-episode psychotic patients.

Indexed as

MethamphetaminePsychotic DisordersCalciumCholecalciferolChronic DiseaseC-Reactive ProteinCross-Sectional StudiesHumansIranParathyroid HormonePhosphorusVitamin DCalciumCholecalciferolC-Reactive ProteinMethamphetamineParathyroid HormonePhosphorusVitamin DAcute psychotic episodeBipolar disorderBPRSCRPPsychiatric disordersPsychosisPTHSchizophreniaVitamin DWith methamphetamine-induced psychotic disorder

Identifiers

PMID37803327
PMCPMC10557165
OpenAlexW4387401793

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.